Form 4: Definitive Healthcare Executive's Tax-Related Stock Sale

Sentiment:

Insider Transaction Report


Definitive Healthcare's Executive Chairman, Jason Krantz, reported a tax-related disposition of 4,093 Class A Common Stock shares.

Summary

  • Jason Ronald Krantz, Executive Chairman, Director, and 10% Owner of Definitive Healthcare Corp. (DH), reported a transaction.
  • On September 14, 2025, Krantz disposed of 4,093 shares of Class A Common Stock.
  • This disposition was a tax-related withholding by the Issuer at a price of $4.15 per share.
  • The shares were withheld to satisfy tax obligations related to the vesting and settlement of previously reported restricted stock units.
  • Following this transaction, Krantz directly beneficially owns 1,079,380 shares of Class A Common Stock.
  • Additionally, Krantz indirectly beneficially owns 450,000 shares through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), where he is the beneficiary.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares following the vesting of restricted stock units, which is a common occurrence for executives and does not reflect a change in the company's operational performance or the insider's long-term view.

Positives

  • The transaction is a routine tax-related event, indicating the vesting of previously granted equity awards.

Negatives

  • A reduction in direct beneficial ownership by 4,093 shares, although for tax purposes.

Risks

  • No new specific risks are introduced by this routine tax-related transaction.

Future Outlook

No forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which typically has no direct bearing on broader industry trends or competitive landscape.

Related Party Transactions

  • Jason Krantz indirectly owns 450,000 shares through DH Holdings (f/k/a Jason R. Krantz 2009 Trust), of which he is the beneficiary. This represents a continuing related party ownership structure.

Stakeholder Impact

  • Shareholders: Minimal impact as it is a routine tax-related transaction, not a discretionary sale, and represents a small fraction of total holdings.
  • Employees: No direct impact.
  • Customers: No direct impact.
  • Suppliers: No direct impact.
  • Creditors: No direct impact.

Key Dates

DateDescription
09/14/2025Transaction date for the disposition of Class A Common Stock.
09/16/2025Date the Form 4 was filed with the SEC.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and typically do not signal a change in the company's fundamental outlook or the insider's long-term investment conviction. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Definitive Healthcare, DH, Jason Krantz, Form 4, insider transaction, stock sale, tax withholding, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.